Investors and Media

Investors and Media

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Corporate Profile

Corporate Presentation

Corporate Presentation

Apr 5, 2024

Apr 5, 2024

ASX Announcements

Notice of change of interests of substantial holder-CMB

Notice of change of interests of substantial holder-CMB

Jul 19, 2024

Jul 19, 2024

Chagne of directors interest

Chagne of directors interest

Jul 12, 2024

Jul 12, 2024

Consolidation Completion

Consolidation Completion

Jul 12, 2024

Jul 12, 2024

Appendix 3H - Notification of cessation of securities

Appendix 3H - Notification of cessation of securities

Jul 9, 2024

Jul 9, 2024

Change in substantial holding-Cyntec

Change in substantial holding-Cyntec

Jul 4, 2024

Jul 4, 2024

For all Cambium Bio Limited ASX market announcements, click here

Financial Information

Cambium Bio Limited Half Year Report

Cambium Bio Limited Half Year Report

Dec 31, 2023

Dec 31, 2023

Cambium Bio Limited Annual Report

Cambium Bio Limited Annual Report

Jun 30, 2023

Jun 30, 2023

News Releases

Regeneus trebles on back of merger deal (Sydney Morning Herald)

Regeneus trebles on back of merger deal (Sydney Morning Herald)

Apr 5, 2024

Apr 5, 2024

Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease

Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease

Feb 6, 2024

Feb 6, 2024

Events and Presentations

Meet Cambium Bio team at BIO International Convention in San Diego

Meet Cambium Bio team at BIO International Convention in San Diego

Apr 17, 2024

Apr 17, 2024